Sanne Hoeks

Chapter 6 96 REFERENCES 1. Gilman, Goodman, Hardman, Limbird. Goodman and Gilman’s the pharmacological basis of therapeutics. New York: McGraw-Hill; 2001. 2. Dinarello CA. Historical insights into cytokines. Eur J Immunol . Nov 2007;37 Suppl 1:S34-45. doi:10.1002/ eji.200737772 3. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet . Nov 2001;29(3):301-5. doi:10.1038/ng756 4. Jin Y, Mailloux CM, Gowan K, et al. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med . Mar 2007;356(12):1216-25. doi:10.1056/NEJMoa061592 5. Feldmann M, Maini RN, Bondeson J, Taylor P, Foxwell BM, Brennan FM. Cytokine blockade in rheumatoid arthritis. Adv Exp Med Biol . 2001;490:119-27. doi:10.1007/978-1-4615-1243-1_13 6. Netea MG, Joosten LA, Lewis E, et al. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med . Jun 2006;12(6):650-6. doi:10.1038/nm1415 7. Sims JE, March CJ, Cosman D, et al. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science . Jul 1988;241(4865):585-9. doi:10.1126/science.2969618 8. Elliott MJ, Maini RN, Feldmann M, et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum . Dec 1993;36(12):1681-90. doi:10.1002/art.1780361206 9. Feldmann M, Maini RN. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol . 2001;19:163-96. doi:10.1146/annurev.immunol.19.1.163 10. Mayor S. Severe adverse reactions prompt call for trial design changes. BMJ . Mar 2006;332(7543):683. doi:10.1136/ bmj.332.7543.683 11. Goodyear M. Learning from the TGN1412 trial. BMJ . Mar 2006;332(7543):677-8. doi:10.1136/bmj.38797.635012.47 12. Group. BDW. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther . Mar 2001;69(3):89-95. doi:10.1067/mcp.2001.113989 13. Sapsford KE, Tezak Z, Kondratovich M, Pacanowski MA, Zineh I, Mansfield E. Biomarkers to improve the benefit/risk balance for approved therapeutics: a US FDA perspective on personalized medicine. Ther Deliv . Nov 2010;1(5):631- 41. doi:10.4155/tde.10.62 14. Panicker G, Meadows KS, Lee DR, Nisenbaum R, Unger ER. Effect of storage temperatures on the stability of cytokines in cervical mucous. Cytokine . Feb 2007;37(2):176-9. doi:10.1016/j.cyto.2007.03.006 15. de Jager W, Hoppenreijs EP, Wulffraat NM, Wedderburn LR, Kuis W, Prakken BJ. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis . May 2007;66(5):589- 98. doi:10.1136/ard.2006.061853 16. Corcoran AT, Yoshimura N, Tyagi V, Jacobs B, Leng W, Tyagi P. Mapping the cytokine profile of painful bladder syndrome/interstitial cystitis in human bladder and urine specimens. World J Urol . Feb 2013;31(1):241-6. doi:10.1007/ s00345-012-0852-y 17. Thorman R, Lundahl J, Yucel-Lindberg T, Hylander B. Inflammatory cytokines in saliva: early signs of metabolic disorders in chronic kidney disease. A controlled cross-sectional study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod . Nov 2010;110(5):597-604. doi:10.1016/j.tripleo.2010.07.007 18. Brandsma D, Voest EE, de Jager W, et al. CSF protein profiling using Multiplex Immuno-assay: A potential new diagnostic tool for leptomeningeal metastases. J Neurol . Sep 2006;253(9):1177-84. doi:10.1007/s00415-006-0187-y 19. Switalla S, Lauenstein L, Prenzler F, et al. Natural innate cytokine response to immunomodulators and adjuvants in human precision-cut lung slices. Toxicol Appl Pharmacol . Aug 2010;246(3):107-15. doi:10.1016/j.taap.2010.04.010 20. Ricker LJ, Kijlstra A, Kessels AG, et al. Interleukin and growth factor levels in subretinal fluid in rhegmatogenous retinal detachment: a case-control study. PLoS One . Apr 2011;6(4):e19141. doi:10.1371/journal.pone.0019141 21. Kreiner F, Langberg H, Galbo H. Increased muscle interstitial levels of inflammatory cytokines in polymyalgia rheumatica. Arthritis Rheum . Dec 2010;62(12):3768-75. doi:10.1002/art.27728